DURHAM, N.C.--(BUSINESS WIRE)--Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced it has completed enrollment for both ongoing global Phase 3 VIOLET clinical trials for VT-1161 ahead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results